Polpharma Biologics, European Biotechnology Company, Selects Box

Polpharma Biologics, a European biotechnology company, has selected Box as its integrated solution for secure collaboration and Intelligent Content Management, centralizing its regulated and sensitive content in the cloud. By adopting Box Enterprise Plus, Polpharma Biologics aims to standardize both regulated and unregulated content on a validated platform, enhancing secure access and collaboration among teams and partners during drug manufacturing processes. Key features such as Box GxP Validation and consulting services facilitate accelerated validation and adoption across departments like Research and Development, Regulatory Affairs, and Quality Assurance. With Box's innovative approach to GxP compliance, Polpharma Biologics joins other leading life sciences organizations, such as Amgen and Allergan, in leveraging technology to streamline research and development while ensuring security and compliance.

No tracked trend matches for this post yet.

Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.